Mylan Ripped Off the Government, Ironically by Misclassifying EpiPens as a Generic Drug

The US government spent over $1.3 billion on EpiPens from 2011 to 2015. But Mylan, the makers of EpiPen, has been overcharging the government for the life-saving allergy medication by misclassifying it as a generic, rather than a name brand drug. If you don’t know whether to laugh or cry at this point, you’re not…

How Congress, the FDA, and Sarah Jessica Parker Helped EpiPen Become a $1 Billion Business

EpiPen, the life-saving allergy product, is now a $1 billion a year business for Mylan, a drug company that’s currently enduring a wave of bad publicity over the extraordinary surge in EpiPen pricing. In 2007, an EpiPen cost about $57. Today that price has skyrocketed to over $600—all for about $1 worth of injectable…